Coronary artery disease or ischemic heart disease is a group of cardiovascular diseases that includes: stable and unstable angina, myocardial infarction (MI), and sudden cardiac death. CAD was the most common cause of death globally…. Read More »

A biomarker is a measurable entity that can help detect and treat diseases earlier and more effectively, they also potentially reduce the financial cost pressuring healthcare providers today. Medical imaging could have a great impact on progressive diseases, such as certain types of cancer, atherosclerotic cardiovascular diseases, Alzheimer’s disease and rheumatoid arthritis…. Read More »

A stroke (Cerebrovascular Accident) is the third most common cause of death and the second leading cause of neurological disability after Alzheimer’s disease in the western world. However, in recent decades its incidence decreased, but the disease in itself remains the leading cause of invalidity and loss of independence among adults…… Read More »

Validation of Quantitative Imaging Biomarkers The FDA makes a distinction between white-listing (approval or clearance) of a diagnostic drug or device for commercial purposes and qualification of a measurement itself to be used as a biomarker in clinical trials. Approval is only available after demonstrating the safety and effectiveness of a device or drug. However,…… Read More »

Erysipelas (РОЖА, التهاب الحمرة الجلدي) Erysipelas (РОЖА, ἐρυσίπελας, Red skin, ignis sacer, holy fire, St. Anthony’s fire, التهاب الحمرة الجلدي) is an acute bacterial dermatological infection caused by b -hemolytic streptococcus group A (bacteria) and involving the upper dermis and subcutaneous tissue that characteristically extends into the regional lymphatic nodes (superficial cutaneous lymphatic nodes, Lymphangitis…… Read More »

© 2024 Medcoi LLC, all rights reserved.
go to top